| Serial Number | 88004821 |
| Word Mark | M MICROBIX |
| Filing Date | Monday, June 18, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 25, 2024 |
| Registration Number | 7424197 |
| Registration Date | Tuesday, June 25, 2024 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, April 9, 2024 |
| Description of Mark | The mark consists of "MICROBIX" underneath a stylized "M". |
| Goods and Services | laboratory instruments for the detection pathogens and toxins in a biological sample for research use; Instruments for the processing of cells and cell derived materials, namely, flow cytometers and flow-based analyzers that detect and analyze nucleic acid content for scientific, laboratory, and general research use; laboratory instruments that detect pathogens in a biological sample for research use; Instruments for the processing of cells and cell derived materials |
| Goods and Services | urokinase used to treat blood clots; Thrombolytic drugs, namely, plasminogen activating drugs and fibrinolytic drugs; urokinase preparations for the restoration of patency to central venous catheters obstructed by clotted blood or fibrin; urokinase preparations for treating pulmonary embolism; urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; urokinase preparations for treating thrombosis; urokinase preparations for treating coronary artery thrombosis; urokinase preparations for treating myocardial infarction; urokinase preparations for the lysis of thrombi; urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; urokinase preparations for treating deep vein thrombosis; urokinase preparations for treating pleural effusions; urokinase preparations for treating peripheral arterial occlusion; urokinase preparations for treating ischemic stroke; urokinase preparations for treating lower limb ischemia; test samples used in conjunction with laboratory diagnostics in the nature of biological or biochemical samples used to verify the reliability of laboratory equipment; test samples used in conjunction with assay methods in the nature of biological or biochemical assay samples used to verify the reliability of laboratory tests; Liquid, frozen and lyophilized inactivated, native pathogens, including whole and fragmented eukaryotes, prokaryotes, and viruses, independent and in host cells, all for in vitro and in vivo scientific or diagnostic use; inactivated, native pathogens, namely, liquid, frozen or lyophilized recombinant DNA and/or RNA preparations, either purified or within host organisms, in various buffers, singly and in combination, all for in vitro and in vivo scientific or diagnostic use; Positive controls, namely, reagents for use with nucleic-acid-based, immunologic, or other diagnostic tests to confirm proper test operation, and run in conjunction with patient samples run to confirm, assess, test, or verify the operation of the test method; proficiency test samples in the nature of biological test samples used to test the proficiency of technicians who use infectious disease diagnostics test systems to determine the pathogenic or biochemical content of samples; Diagnostic reagents in the nature of biotechnology products for medical and veterinary use, namely, micro-organisms for amplification controls; Diagnostic kits for in-vitro scientific and diagnostic use; Laboratory assay kits for scientific and diagnostic use; Biological material for scientific or diagnostic purposes, in the nature of serum and plasma from infected and disease state individuals used for verification and validation of human diagnostic assays for such infections and diseases; Biotechnology products for scientific or diagnostic purposes, namely, reagents and solutions in the nature of viruses, bacteria, fungi, parasites, and derivatives thereof used to research, develop, manufacture, and validate infectious disease diagnostic tests; biochemical products, namely, antibodies for scientific or research use; diagnostic reagents containing lyophilized microorganisms, and reagents containing lyophilized microorganisms all for in-vitro use and for use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific research use; diagnostic reagents for medical research use; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; diagnostic preparations for medical research use; diagnostic preparations for scientific research use |
| Goods and Services | Biochemical agents for in vitro and in vivo scientific or diagnostic use, namely, viruses, bacteria, parasites, and purified and unpurified whole, fragmented, and fractionated pathogens and pathogenic organisms; Cells and cell culture derived products for in vitro or in vivo scientific or diagnostic use, namely, for production of organisms, proteins, nucleic acids, or cellular fractions used as reagents or antigens, test articles, or controls; antibodies and thrombolytics for in vitro scientific or research use; Biochemicals in the form of monoclonal antibodies for in vitro scientific use; Biochemicals in the form of monoclonal antibodies for research use; Active Pharmaceutical Ingredients to stimulate blood-clot dissolving processes; Microbial antigens and antisera for in vitro diagnostic use |
| Goods and Services | Licensing of process technology used in the manufacturing of vaccines |
| Goods and Services | Animal husbandry services; animal breeding services; sperm- and semen-sexing services in the nature of in vitro fertilization services; biological cell-selection services for medical purposes in the nature of in vitro fertilization services; medical services in the field of in vitro fertilization, namely, services of delivering energy to a population of biological cells for the purpose of selecting desired cells and negatively selecting undesired cells |
| Goods and Services | automated flow cytometer sample introduction accessories used in conjunction with a flow cytometer to deliver biological and chemical samples from single test tubes and multiwell laboratory plates; medical apparatus for the automated analysis of cells in the nature of cytometers for medical diagnostic use; medical apparatus for the automated cytometric analysis of cells in the nature of cytometers for medical diagnostic use; medical apparatus in the nature of cytometers that detect atypia in cells for medical diagnostic use; medical apparatus for automated analysis of nuclear features for the detection of neoplasms and cancer and genetic conditions; apparatus for medical diagnostic uses in the nature of an automated flow cytometer sample introduction accessory, namely, a machine which is used in conjunction with a flow cytometer to deliver biological and chemical samples from single test tubes and multi-well laboratory plates |
| Goods and Services | Providing diagnostic testing services, laboratory tests; production for others of cells, cell lines, viruses, bacteria, and pathogens, proteins, or nucleic acids in whole or in part; Research and development services in the field of process technology used in the manufacture of vaccines; process technology services to be used in the manufacture of a vaccine; biological cell-selection services for biological research purposes; biological research services of delivering energy to a population of biological cells for the purpose of selecting desired cells and negatively selecting undesired cells |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 11, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 11, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 11, 2019 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 11, 2019 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 22, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 22, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 11, 2019 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Microbix Biosystems Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Mississauga, Ontario L4Z1P3 CA |
| Party Name | Microbix Biosystems Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Mississauga, Ontario L4Z1P3 CA |
| Party Name | Microbix Biosystems Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Mississauga, Ontario L4Z1P3 CA |
| Event Date | Event Description |
| Wednesday, October 10, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, June 21, 2018 | NEW APPLICATION ENTERED |
| Friday, June 22, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 4, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, October 10, 2018 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 10, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 10, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 10, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 11, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 24, 2019 | SUSPENSION LETTER WRITTEN |
| Wednesday, April 24, 2019 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, April 24, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, November 15, 2019 | ASSIGNED TO LIE |
| Wednesday, December 4, 2019 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, December 9, 2019 | SUSPENSION INQUIRY WRITTEN |
| Monday, December 9, 2019 | INQUIRY TO SUSPENSION E-MAILED |
| Monday, December 9, 2019 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Friday, June 5, 2020 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, June 10, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 10, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 12, 2020 | SUSPENSION LETTER WRITTEN |
| Friday, June 12, 2020 | LETTER OF SUSPENSION E-MAILED |
| Friday, June 12, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, March 24, 2021 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, April 8, 2021 | SUSPENSION INQUIRY WRITTEN |
| Thursday, April 8, 2021 | INQUIRY TO SUSPENSION E-MAILED |
| Thursday, April 8, 2021 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Tuesday, October 5, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, October 12, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 12, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 20, 2021 | SUSPENSION LETTER WRITTEN |
| Wednesday, October 20, 2021 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, October 20, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, May 25, 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, June 9, 2022 | SUSPENSION INQUIRY WRITTEN |
| Thursday, June 9, 2022 | INQUIRY TO SUSPENSION E-MAILED |
| Thursday, June 9, 2022 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Monday, December 12, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 5, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, December 12, 2022 | ASSIGNED TO LIE |
| Monday, December 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 14, 2022 | SUSPENSION LETTER WRITTEN |
| Wednesday, December 14, 2022 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, December 14, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, July 6, 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, July 26, 2023 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, July 26, 2023 | INQUIRY TO SUSPENSION E-MAILED |
| Wednesday, July 26, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Tuesday, October 24, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, October 25, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 25, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 28, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, December 28, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, December 28, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 20, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, February 20, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 20, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 20, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, February 22, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 1, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, March 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 9, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 25, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 25, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |